We spend a lot of time thinking about the difficult people in our lives—the friend who can't take feedback, the partner who always has to be right, the coworker who turns everything into a fight. But ...

One idle evening last October, Mehtaab Sawhney took up an old pastime. He began perusing the website erdosproblems.com, an updated record of the 1,179 conjectures left behind by the eccentric and ...

What are the most pressing global crises in 2026? Each year, the International Rescue Committee’s (IRC) Emergency Watchlist identifies the countries at greatest risk of new or worsening humanitarian ...

Five years ago, mathematicians Dawei Chen and Quentin Gendron were trying to untangle a difficult area of algebraic geometry involving differentials, elements of calculus used to measure distance ...

Microsoft’s MSFT-0.63%decrease; red down pointing triangle Copilot chatbot has become central to its artificial-intelligence strategy as the company’s close partnership with OpenAI diminishes. But the ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Artificial Intelligence 'I violated every principle I was given': AI agent deletes company's entire database in 9 seconds, then confesses Cancer New AI model spots pancreatic cancer up to 3 years ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...